Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

TB prevention news

Show

From To
Isoniazid alone prevents tuberculosis in people with advanced HIV, urine test may lower mortality

Using isoniazid alone to prevent the development of active tuberculosis (TB) in people with advanced HIV disease was equally effective and better tolerated than a common four-drug empirical

Published
25 March 2016
By
Liz Highleyman
Proactively treating HIV patients at risk for tuberculosis with multidrug TB therapy doesn’t save more lives

In what investigators say is a surprise finding, results of a new study appear to strongly affirm the effectiveness of prescribing the anti-tuberculosis drug isoniazid alone — in place of the standard four-drug regimen — to prevent TB and reduce death in people with advanced HIV/AIDS infections. Those with HIV and AIDS are highly susceptible to TB.

Published
21 March 2016
From
Johns Hopkins Medicine
Screen High-Risk Adults for Tuberculosis, Experts Say

Adults at greater risk for latent tuberculosis infection should be screened for the condition, the U.S. Preventive Services Task Force recommends.

Published
09 March 2016
From
U.S. News & World Report
Three-month isoniazid/pyrazinamide regimen prevents TB as well as 6-month isoniazid in people living with HIV

A daily three-month regimen of isoniazid and pyrazinamide is just as effective at preventing the development of active tuberculosis (TB) as a six-month course of isoniazid in

Published
22 October 2015
By
Keith Alcorn
Presumptive treatment of TB in advanced HIV no better than giving ART and isoniazid

Giving treatment for tuberculosis to all people with very advanced HIV disease at the time they start antiretroviral therapy, before a laboratory diagnosis of TB –

Published
21 July 2015
By
Keith Alcorn
Starting HIV treatment at CD4 count above 500 reduces the risk of serious illness and death by 44%, African Temprano trial shows

Starting HIV treatment at a CD4 cell count above 500 reduced the risk of serious illness including tuberculosis (TB), and death, by 44% when compared to starting

Published
26 February 2015
By
Keith Alcorn
XDR-TB in South Africa is largely spread person-to-person, not by failure of drug treatment

The vast majority of people with extensively drug-resistant tuberculosis (XDR-TB) diagnosed in the world’s most extensive outbreak have acquired their infection from another person, not as the

Published
26 February 2015
By
Keith Alcorn
European HIV response "falling behind" as Eastern European epidemic grows

HIV diagnoses have increased by 80% in the European region since 2004, and three quarters of new HIV diagnoses in the European region are occurring in Eastern

Published
05 December 2014
By
Keith Alcorn
Sanofi: FDA Approves Priftin Tablets To Treat Latent Tuberculosis Infection

French drug maker Sanofi announced Tuesday that Priftin (rifapentine) tablets for the treatment of latent tuberculosis infection has received approval from the U.S. Food and Drug Administration.

Published
02 December 2014
From
RTT News
Call to action to halt the looming TB-diabetes co-epidemic

It is time to act and no time to waste. That is the urgent message of the report "The Looming Co-epidemic of TB-Diabetes: A Call to Action" launched jointly by the International Union Against Tuberculosis and Lung Disease (The Union) and the World Diabetes Foundation (WDF) at the opening day of the 45th Union World Conference on Lung Health in Barcelona. The report warns against the brewing storm of diabetes and tuberculosis (TB) that is no longer confined to the teacup.

Published
29 October 2014
From
Citizen News Service
← First12345...11Next →

Filter by country